more akkad: AAN: Doctors caution against prescribing attention-boosting drugs for healthy kids

AAN: Doctors caution against prescribing attention-boosting drugs for healthy kids

Public release date: 13-Mar-2013
[ | E-mail |

Share ]

Contact: Rachel Seroka
rseroka@aan.com
612-928-6129
American Academy of Neurology

MINNEAPOLIS The American Academy of Neurology (AAN), the world's largest professional association of neurologists, is releasing a position paper on how the practice of prescribing drugs to boost cognitive function, or memory and thinking abilities, in healthy children and teens is misguided. The statement is published in the March 13, 2013, online issue of Neurology, the medical journal of the American Academy of Neurology.

This growing trend, in which teens use "study drugs" before tests and parents request ADHD drugs for kids who don't meet the criteria for the disorder, has made headlines recently in the United States. The Academy has spent the past several years analyzing all of the available research and ethical issues to develop this official position paper.

"Doctors caring for children and teens have a professional obligation to always protect the best interests of the child, to protect vulnerable populations, and prevent the misuse of medication," said author William Graf, MD, of Yale University in New Haven, Conn., and a member of the American Academy of Neurology. "The practice of prescribing these drugs, called neuroenhancements, for healthy students is not justifiable."

The statement provides evidence that points to dozens of ethical, legal, social and developmental reasons why prescribing mind-enhancing drugs, such as those for ADHD, for healthy people is viewed differently in children and adolescents than it would be in functional, independent adults with full decision-making capacities. The Academy has a separate position statement that addresses the use of neuroenhancements in adults.

The article notes many reasons against prescribing neuroenhancement including: the child's best interest; the long-term health and safety of neuroenhancements, which has not been studied in children; kids and teens may lack complete decision-making capacities while their cognitive skills, emotional abilities and mature judgments are still developing; maintaining doctor-patient trust; and the risks of over-medication and dependency.

"The physician should talk to the child about the request, as it may reflect other medical, social or psychological motivations such as anxiety, depression or insomnia. There are alternatives to neuroenhancements available, including maintaining good sleep, nutrition, study habits and exercise regimens," said Graf.

###

The statement had no industry sponsors.

View the AAN's full statement on neuroenhancements and adults at: http://www.neurology.org/content/early/2009/09/23/WNL.0b013e3181beecfe.full.pdf

The American Academy of Neurology, an association of more than 25,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer's disease, stroke, migraine, multiple sclerosis, brain injury, Parkinson's disease and epilepsy.

For more information about the American Academy of Neurology, visit http://www.aan.com or find us on Facebook, Twitter, Google+ and YouTube.

Media Contacts:
Rachel Seroka
Angela Babb, APR, ababb@aan.com, 612-928-6102

[ | E-mail | Share ]
?

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.

AAN: Doctors caution against prescribing attention-boosting drugs for healthy kids Public release date: 13-Mar-2013
[ | E-mail | Share ]
Contact: Rachel Seroka
rseroka@aan.com
612-928-6129
American Academy of Neurology